Loading…
A Placebo-Controlled Add-On Trial of the Ampakine, CX516, for Cognitive Deficits in Schizophrenia
Goff, Donald C, Lamberti, J Steven, Leon, Andrew C, Green, Michael F, Miller, Alexander L, Patel, Jayendra, Manschreck, Theo, Freudenreich, Oliver, Johnson, Steven A
Published in Neuropsychopharmacology (New York, N.Y.) (01.02.2008)
Published in Neuropsychopharmacology (New York, N.Y.) (01.02.2008)
Get full text
Journal Article
Loading…
A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: A gynecologic oncology group study
Monk, Bradley J., Blessing, John A., Street, Daron G., Muller, Carolyn Y., Burke, James J., Hensley, Martee L.
Published in Gynecologic oncology (01.01.2012)
Published in Gynecologic oncology (01.01.2012)
Get full text
Journal Article
Loading…
Loading…
Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial
Berry-Kravis, Elizabeth, Krause, Sue Ellen, Block, Sandra S, Guter, Steve, Wuu, Joanne, Leurgans, Sue, Decle, Penelope, Potanos, Kristina, Cook, Edwin, Salt, Jeff, Maino, Dominick, Weinberg, Dahlia, Lara, Rebecca, Jardini, Tristan, Cogswell, Jennifer, Johnson, Steven A, Hagerman, Randi
Published in Journal of child and adolescent psychopharmacology (01.10.2006)
Published in Journal of child and adolescent psychopharmacology (01.10.2006)
Get full text
Journal Article
Loading…
Mechanism-based pharmacokinetic/pharmacodynamic meta-analysis of trabectedin (ET-743, Yondelis) induced neutropenia
Hing, J, Perez-Ruixo, J J, Stuyckens, K, Soto-Matos, A, Lopez-Lazaro, L, Zannikos, P
Published in Clinical pharmacology and therapeutics (01.01.2008)
Published in Clinical pharmacology and therapeutics (01.01.2008)
Get more information
Journal Article
Loading…